Clinical Trial Update: Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1 study evaluating NMRA-323511 in healthy elderly adults and in adults with agitation associated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NMRA-323511

Snippet

Sponsor: Neumora Therapeutics, Inc. | Conditions: Alzheimer's Disease, Healthy Elderly | Phase 1 | Status: COMPLETED